​

Atara Biotherapeutics (ATRA) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Atara Biotherapeutics Revenue Highlights

Latest Revenue (Y)

$8.57M

Latest Revenue (Q)

$40.19M

Atara Biotherapeutics Revenue by Period

Atara Biotherapeutics Revenue by Year

DateRevenueChange
2023-12-31$8.57M-86.51%
2022-12-31$63.57M212.55%
2021-12-31$20.34M100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31-100.00%
2014-12-31-100.00%
2013-12-31--

Atara Biotherapeutics generated $8.57M in revenue during NA 2023, up -86.51% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Atara Biotherapeutics Revenue by Quarter

DateRevenueChange
2024-09-30$40.19M40.33%
2024-06-30$28.64M4.69%
2024-03-31$27.36M543.39%
2023-12-31$4.25M98.88%
2023-09-30$2.14M123.41%
2023-06-30$957.00K-21.94%
2023-03-31$1.23M454.75%
2022-12-31$221.00K-95.04%
2022-09-30$4.46M-91.36%
2022-06-30$51.58M605.21%
2022-03-31$7.31M-3.10%
2021-12-31$7.55M40.56%
2021-09-30$5.37M38.76%
2021-06-30$3.87M8.95%
2021-03-31$3.55M-99.01%
2020-12-31$358.19M100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-06-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31--

Atara Biotherapeutics generated $40.19M in revenue during Q3 2024, up 40.33% compared to the previous quarter, and up 4199.58% compared to the same period a year ago.

Atara Biotherapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
APLSApellis Pharmaceuticals$366.28M$176.57M
KPTIKaryopharm Therapeutics$146.03M$29.52M
HRTXHeron Therapeutics$127.04M$36.02M
RCUSArcus Biosciences$117.00M$48.00M
FATEFate Therapeutics$63.53M$6.77M
CRBUCaribou Biosciences$34.48M$3.46M
TCRXTScan Therapeutics$21.05M-
HOOKHOOKIPA Pharma$20.13M-
ITOSiTeos Therapeutics$12.60M$35.00M
MREOMereo BioPharma Group$10.00M-
ATRAAtara Biotherapeutics$8.57M$40.19M
BTAIBioXcel Therapeutics$1.38M$1.10M
ALLOAllogene Therapeutics$95.00K-
XFORX4 Pharmaceuticals-$560.00K
ABOSAcumen Pharmaceuticals--
SANASana Bio--

ATRA Revenue FAQ

What is Atara Biotherapeutics’s yearly revenue?

Atara Biotherapeutics's yearly revenue for 2023 was $8.57M, representing a decrease of -86.51% compared to 2022. The company's yearly revenue for 2022 was $63.57M, representing an increase of 212.55% compared to 2021. ATRA's yearly revenue for 2021 was $20.34M, representing an increase of 100.00% compared to 2020.

What is Atara Biotherapeutics’s quarterly revenue?

Atara Biotherapeutics's quarterly revenue for Q3 2024 was $40.19M, a 40.33% increase from the previous quarter (Q2 2024), and a 1779.79% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $28.64M, a 4.69% increase from the previous quarter (Q1 2024), and a 2892.69% increase year-over-year (Q2 2023). ATRA's quarterly revenue for Q1 2024 was $27.36M, a 543.39% increase from the previous quarter (Q4 2023), and a 2131.40% increase year-over-year (Q1 2023).

What is Atara Biotherapeutics’s revenue growth rate?

Atara Biotherapeutics's revenue growth rate for the last 3 years (2021-2023) was -57.85%, and for the last 5 years (2019-2023) was 0%.